Lucid Diagnostics share price logo

Lucid Diagnostics

NASDAQ: LUCD

$0.83

-0.01

(-1.43%)

as on

Lucid Diagnostics Stock Performance

as on September 26, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.82
    $0.85
    downward going graph

    0.73%

    Downside

    2.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.75
    $1.63
    downward going graph

    9.20%

    Downside

    97.25%

    Upside

    downward going graph

Lucid Diagnostics share price movements today

Previous Close
$0.84
Open
$0.84
Volume
2.1M
Market Cap
$160.0M
Day's Low - High
$0.82 - $0.85
52 Week Low - High
$0.75 - $1.63

Lucid Diagnostics Historical Returns

1 Month Return
-14.91 %
3 Month Return
-23.52 %
1 Year Return
-19.81 %
3 Year Return
-44.19 %
5 Year Return
0 %

Lucid Diagnostics Stock Fundamentals & Key Indicators

Check Lucid Diagnostics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$160.0M

EPS (TTM)

-0.4661

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.8

Industry PE ratio

-2.33

PEG Ratio

-0.023180438780783675

EBITDA

-51.4M

Revenue (TTM)

5.4M

Profit Margin

-25.79%

Return On Equity TTM

-404.34%

Lucid Diagnostics Stock Valuation

Track how Lucid Diagnostics P/E has moved over time to understand its valuation trends.

Lucid Diagnostics in the last 5 years

  • Overview

  • Trends

Lowest (-6.90x)

December 31, 2021

Industry (-2.33x)

December 31, 2025

Today (-1.58x)

December 31, 2025

Highest (-0.78x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.58x

Lucid Diagnostics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lucid Diagnostics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Lucid Diagnostics image
Lucid Diagnostics
Buy$160.0MNA-1.8-25.79%0.00%
Edwards Lifesciences image
Edwards Lifesciences
Buy$49.4B-28.13%49.2777.98%0.00%
Medtronic image
Medtronic
Buy$116.1B-31.83%21.6466.69%3.19%
Abbott Laboratories image
Abbott Laboratories
StrongBuy$179.4B-18.56%32.556.80%2.40%
Stryker image
Stryker
StrongBuy$105.5B-1.55%27.7265.17%1.27%
See all

Stock Returns calculator for Lucid Diagnostics Stock including INR - Dollar returns

The Lucid Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lucid Diagnostics investment value today

Current value as on today

₹86,654

Returns

-₹13,346

(-13.35%)

Returns from Lucid Diagnostics Stock

-₹19,806 (-19.81%)

Dollar Impact

₹6,460 (+6.46%)

Analyst Recommendation on Lucid Diagnostics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Lucid Diagnostics. Average target price of $4

Lucid Diagnostics Share Price Target

Get share price movements and forecasts by analysts on Lucid Diagnostics.

What analysts predicted

79.35%UPSIDE

Target Price

$4

Current Price

$0.826

Analyzed by

2 Analysts

High

$3

Target

$4.00

Low

$2.5

Lucid Diagnostics target price $4, a slight upside of 79.35% compared to current price of $0.826. According to 2 analysts rating.

Indian Investors' Interest in Lucid Diagnostics Stock

Search interest for Lucid Diagnostics Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-18% versus previous 30 day period

Lucid Diagnostics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
0
1
1
0
1
1
1
1
1
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-10
-11
-11
-12
-12
-11
-11
-14
-12
-12
EBITDA
-10
-10
-12
-11
-26
-4
-10
-16
-13
-11
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-11
-12
-11
-26
-4
-10
-16
-13
-11
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-10
-11
-12
-11
-26
-4
-10
-16
-13
-11
Net Profit Margin
-65.43%
-65.37%
-43.69%
-79.20%
-87.32%
-53.48%
-40.13%
-23.67%
-47.05%
1.97%

Lucid Diagnostics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
0
0
2
4
4
Gross Profit
-
-
-
0
-3
-6
-3
-2
Operating Income
-1
-4
-8
-27
-56
-48
-46
-49
EBITDA
0
-
0
-27
-54
-49
-44
-57
Interest Expense
-
-
-
0
0
0
0
0
Depreciation
1
4
8
0
1
2
1
0
Income Before Tax
-1
-4
-8
-28
-56
-52
-45
-58
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-1
-4
-8
-28
-56
-52
-45
-58
Net Profit Margin
0.00%
0.00%
0.00%
-17.00%
-858.62%
-249.18%
-90.20%
-60.26%

Lucid Diagnostics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
-11
-12
-11
-26
-4
-10
-26,652
-13
-11
Operating Cash Flow
-12
-11
-10
-9
-12
-10
-10
-12
-12
-11
Investing Cash Flow
0
-
0
0
0
0
0
0
0
0
Financing Cash Flow
18
11
0
17
15
16
27
0
5
16
Change in Cash
5
0
-10
7
2
5
16
-12
-6
5

Lucid Diagnostics Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-4
-8
-28
-56
-52
-45
-58
Operating Cash Flow
0
-2
-5
-17
-29
-32
-44
-46
Investing Cash Flow
-
-
-
0
-4
0
0
0
Financing Cash Flow
0
2
5
72
2
29
48
59
Change in Cash
0
0
0
53
-31
-3
3
12

Mutual Funds that own Lucid Diagnostics Stock

Check out the Mutual Funds with significant holdings in Lucid Diagnostics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.003204%
4071392
Fidelity Salem Street Trust
0.476562%
968584
Fidelity Concord Street Trust
0.431417%
876831
RUSSELL INVESTMENT CO
0.313209%
636580
VANGUARD SCOTTSDALE FUNDS
0.259771%
527970
See all

Global Institutional Holdings in Lucid Diagnostics

Funds
Holdings
Vanguard
3.66%
iShares
2.69%
VANGUARD INDEX FUNDS
2%
Fidelity Salem Street Trust
0.48%
Fidelity Concord Street Trust
0.43%
See all

Insights on Lucid Diagnostics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LUCD stock has moved up by 5.1%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -16.26M → -11.68M (in $), with an average increase of 18.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.25M → 1.47M (in $), with an average increase of 14.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 13.2% return, outperforming this stock by 33.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 23.1% return, outperforming this stock by 66.9%

About Lucid Diagnostics

Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key product offerings include EsoGuard, an internally developed esophageal DNA test, and EsoCheck, a specialized device designed for collecting esophageal cells. Formed in 2018, Lucid Diagnostics Inc. has its headquarters in New York, New York, and operates as a subsidiary of PAVmed Inc.
OrganisationLucid Diagnostics
Headquarters360 Madison Avenue, New York City, NY, 10017, US
IndustryMedical - Devices
CEOLishan Aklog
E-voting on sharesClick here to vote

Key Management of Lucid Diagnostics

Name

Title

Dr. Sanford D. Markowitz M.D., Ph.D.

Co-Founder & Strategic Advisor

Dr. Joseph Willis M.D.

Co-founder & Strategic Advisor

Helen Moinova Ph.D.

Co-Founder & Strategic Advisor

Dr. Brian J. deGuzman M.D.

Chief Technology & Compliance Officer

Dr. Amitabh Chak M.D.

Co-Founder & Strategic Advisor

Dr. Suman M. Verma M.D., Ph.D.

Senior VP & Chief Scientific Officer

Dr. Lishan Aklog M.D.

Chairman & CEO

Mr. Shaun M. O'Neill M.B.A.

President & COO

Mr. Dennis M. McGrath C.P.A.

Chief Financial Officer

Mr. Michael Adam Gordon

General Counsel & Secretary

FAQs

What is Lucid Diagnostics share price today?

Lucid Diagnostics share price today is $0.83 as on at the close of the market. Lucid Diagnostics share today touched a day high of $0.85 and a low of $0.82.

What is the 52 week high and 52 week low for Lucid Diagnostics share?

Lucid Diagnostics share touched a 52 week high of $1.63 on and a 52 week low of $0.75 on . Lucid Diagnostics stock price today i.e. is closed at $0.83,which is 49.30% down from its 52 week high and 10.13% up from its 52 week low.

What is Lucid Diagnostics's market capitalisation today?

Lucid Diagnostics market capitalisation is $0.00T as on .

How to invest in Lucid Diagnostics Stock (LUCD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lucid Diagnostics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lucid Diagnostics Shares that will get you 1.8160 shares as per Lucid Diagnostics share price of $0.83 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Lucid Diagnostics Stock (LUCD) from India?

Indian investors can start investing in Lucid Diagnostics (LUCD) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Lucid Diagnostics stock (as per the Rupee-Dollar exchange rate as on ). Based on Lucid Diagnostics share’s latest price of $0.83 as on September 26, 2026 at 8:45 am IST, you will get 12.1065 shares of Lucid Diagnostics. Learn more about fractional shares .